ROME Therapeutics Company
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.” With several drug targets identified and multiple discovery programs underway, ROME is moving rapidly to leverage this new frontier in biology. To lead this exploration, ROME has assembled a team of world-class leaders across fields including oncology, immunology, virology and machine learning.
Funding Status:
Private
Employee Number:
11-50
Last Funding Date:
2023-09-12
Headquarters:
Cambridge,Massachusetts,United States,North America
Founded Date:
2020-01-01
Total Funding:
199000000
Industry:
Quantum Biology
Super Industry:
Quantum Science Applications
Funding Stage:
M&A
Funding Total Value:
199000000
Last Funding Total Usd:
72000000
Last Funding Total Currency:
USD
Last Funding Total Value:
72000000
Founders:
Rosana Kapeller